Our fundamental principle of Velocity Health  ‘All Teach, All Learn’ means we are continually committed to providing and growing beneficial relationships for our start-ups and the ecosystem. By creating an extensive network of healthcare professionals, academics, and corporate members our Velocity Health “explorers “ network will have the opportunity to engage with an incredible ecosystem in digital health; whilst also providing entrepreneurs with the right expertise to accelerate their development. Explorers can join the Velocity Health network by becoming mentors, navigators or collaborators.

Companies

People

Elizabeth Angier

Elizabeth Angier GP, Sheffield Teaching Hospitals NHS Foundation Trust

Elizabeth Angier

GP, Sheffield Teaching Hospitals NHS Foundation Trust

Elizabeth Angier
Elizabeth is a portfolio gp and has several roles in different organisations. She is a clinical associate with the new care models programme in the UK with NHS England advising on primary care, policy pathways and integrated care. She is also secretary of the primary care group EAACI a third sector allergy charity across Europe advising on primary care,policy and allergy. She works in a UK hospital allergy clinic in Sheffield and a GP surgery
X
Lizzie Barclay

Lizzie Barclay Head of B2B Marketing, Yahoo

Lizzie Barclay

Head of B2B Marketing, Yahoo

Lizzie Barclay
Lizzie is Head of UK B2B Marketing at Yahoo. She is highly driven with an outgoing personality and is practical, commercial and creative. Her initiative and strong communication skills allow her to get to the heart of a challenge quickly and to get things done. She previous worked at RBS and was Highly Commended in the Marketing Society’s 2014 Young Marketing Leader of the Year category and a finalist for Marketing Week’s 2014 Rising Star award.
X
Julie Bretland

Julie Bretland CEO, Our Mobile Health

Julie Bretland

CEO, Our Mobile Health

Julie Bretland
Julie Bretland founded Our Mobile Health to improve quality and provide confidence in the digital health sector by assessing health apps for app developers and health care organisations. This builds on a background of developing, launching and managing innovative mobile services for many years for big corporates and start-ups across Europe and Africa. She was an expert advisor on digital health at the London Health Commission and set up DigitalHealth.London on behalf of the 3 London Academic Health Science Networks, MedCity and the London Mayor. She sits on the EU mhealth working group and supports the UK National Information Board in the work of evaluating apps. Julie studied for her MBA at London Business School as a recipient of the prestigious Celia Atkin Advent scholarship. She was a winner of the Deloitte’s Institute of Innovation and Entrepreneurship Founders Award, and is a founding member of the GSM Association’s ‘Connected Women’ programme. Her input has been sought by a variety of academic researchers as well by the Royal Academy of Engineering white paper on Digital Futures and Academy of Medical Sciences white paper on digital health. She is a regular speaker on health innovation. In recent years Julie has been focusing on promoting and assuring quality in digital health in order to provide the health professional community with confidence in digital health tools.
X
Charlie Davie

Charlie Davie MD UCL Partners Academic Science Network and Neuroscience Programme Lead

Charlie Davie

MD UCL Partners Academic Science Network and Neuroscience Programme Lead

Charlie Davie
Charlie joined UCLPartners in 2009 as Stroke Lead and subsequently took on the role of Programme Director for Neurosciences. He became Director of the AHSN in 2014 and Managing Director in May 2015. In October 2016, Charlie was appointed as Interim Managing Director for UCLPartners. Charlie provides strategic leadership for the AHSN and its integrated programmes, as well as providing leadership across UCLPartners. Before joining UCLPartners, Charlie was the clinical lead for stroke services at the Royal Free London NHS Foundation Trust, where he continues his clinical work as Consultant Neurologist. He has also been the stroke lead for the North Central London Cardiovascular and Stroke Network. Charlie played a pivotal role in redesigning stroke services in London, which has resulted in significantly improved outcomes. He has published extensively in several areas of clinical neurology. His current research interests include service reconfiguration and clinical outcomes. He has been an editor of The European Journal of Neurology for over 10 years and serves on the board of the UCL Institute of Digital Health and DigitalHealth.London. Charlie recently represented the 15 AHSNs on the Government’s Life Sciences Cabinet.
X
Kirill Duskhin

Kirill Duskhin Engagement Manager, McKinsey & Co

Kirill Duskhin

Engagement Manager, McKinsey & Co

Kirill Duskhin
Kirill is an Engagement Manager in McKinsey & Co, specialising in innovative care models and commissioner operations. He has worked with multiple comissioners in the UK, as well as on health systems design internationally. He is passionate about prevention, especially enabled by behavioural economics and digital technology. He has an MBA from Harvard and MSc in Economics from Moscow State Institute of International Relations.
X
Dr. Brian Flately

Dr. Brian Flately Lead Research Analyst, HealthXL

Dr. Brian Flately

Lead Research Analyst, HealthXL

Dr. Brian Flately
Brian is passionate about driving change through innovation and collaboration. Brian leads the development and growth of the HealthXL Challenges – collaborative digital health projects between leading healthcare brands, industry and clinical providers, along with some of the most promising tech innovators. To validate the problems raised as challenges, he engages a wide network of clinical and patient advocacy groups across the world. With experience in publishing both peer-reviewed academic publications and industry market analysis, he has a unique skill to digest and report on complex subject matter to a wide audience.
X
Professor Jonathon Gray

Professor Jonathon Gray Director, Ko Awatea

Professor Jonathon Gray

Director, Ko Awatea

Professor Jonathon Gray
Professor Jonathon Gray is the director of Ko Awatea, a hub of education, improvement and innovation that supports health systems and public services and is embedded within the Counties Manukau District Health Board in Aotearoa New Zealand. Jonathon has more than thirty years’ experience in the field of health. Not only is he a doctor with specialist expertise in medical genetics and public health, he also holds numerous visiting fellowships at organisations in the UK including the Institute for Healthcare Improvement. Furthermore, Jonathon is the professor of Health Innovation and Improvement at Victoria University in Wellington, New Zealand, with visiting Chairs at Auckland University of Technology (AUT) and Cardiff University. Find out more about the work Jonathon is leading on the Ko Awatea and APAC Forum websites.
X
Dr Cosima Gretton

Dr Cosima Gretton Guy’s & St Thomas’ NHS Foundation Trust Author at The King’s Fund, Founder at AXNS Collective

Dr Cosima Gretton

Guy’s & St Thomas’ NHS Foundation Trust Author at The King’s Fund, Founder at AXNS Collective

Dr Cosima Gretton
Dr Cosima Gretton is an Academic Foundation Doctor at Guy’s & St Thomas’ NHS Foundation Trust and an expert in digital health. She is currently conducting research for Outcomes-Based Healthcare using machine learning on smartphone sensor data to predict health outcomes in people with diabetes. Alongside clinical practice at St Thomas’ Hospital, she has formed a clinician-led digital health team to help improve the trust’s in-house electronic noting system. She is also a Teaching Fellow on the UCL Technology Entrepreneurship MSc. She consults for digital health start-ups regarding product design for behaviour change, and writes for publications such as WIRED Magazine and the King’s Fund on health technology. She speaks for highly prestigious global organisations on digital health matters. She is an alumnus of the Singularity University Graduate Studies Program in Silicon Valley and a Fellow of the Digital Health Forum, with whom she organises conferences and events across London. Prior to working as a doctor she founded science communication company AXNS Collective, funded by the Wellcome Trust and the Arts Council. She holds a degree in experimental psychology from Oxford University. Cosima has a wealth of further experience which you can find on her LinkedIn
X
Professor Joanne M. Hackett

Professor Joanne M. Hackett Chief Commercial Officer, Precision Medicine Catapult

Professor Joanne M. Hackett

Chief Commercial Officer, Precision Medicine Catapult

Professor Joanne M. Hackett
Joanne is an accomplished entrepreneur, scientist and strategist with experience in the execution and management of complex business transactions. Joanne has been actively involved in clinical research for over 15 years in Canada, America, Germany, Sweden and the UK. Her current responsibilities include creating a portfolio of external investments and strategic alliances which advances technology and product strategies, creates a sustainable competitive advantage, and contributes to attainment of research, development and commercialisation goals. She has broad business development experience, which includes the negotiation, execution and management of hundreds of transactions with Pharma, Biotech, academia and non-profits; including co-development/co-promotion, in/out licensing, collaborative R&D, consortia. She’s highly skilled in manoeuvring and gaining consensus in a matrixed environment and leading cross-functional teams charged with setting external investment strategies and the identification and evaluation of targets.
X
Farhat Hamid

Farhat Hamid Head of Nutrition & Dietetics, London North West Healthcare NHS Trust

Farhat Hamid

Head of Nutrition & Dietetics, London North West Healthcare NHS Trust

Farhat Hamid
Farhat is Head of Nutrition & Dietetics in Brent at London North West Healthcare NHS Trust. She is also the Programme Lead for Move Away from Pre-diabetes (MAP) & Chair of North West London Enteral Feeding Consortium. She holds a particular interest in Primary Prevention, with a focus on chronic disease prevention. She is a highly accomplished senior manager with extensive experience gained in the NHS at a local, regional and national level. With a track record of success in building high performing, dynamic and diverse teams throughout 26 years in management and leadership roles, she combines a proven ability to deliver operational and financial performance objectives with an unstoppable passion to improve health and well-being amongst the wider community.
X
Heather Hancock

Heather Hancock Director of Business and Commercial Operations, MSD UK HH LT

Heather Hancock

Director of Business and Commercial Operations, MSD UK HH LT

Heather Hancock
Heather is a dynamic, charismatic results-driven commercial executive with significant experience in the healthcare industry across strategic and operational functions. She has immense experience of working within medical device and pharmaceutical companies as well as an acute hospital healthcare provider. She also has worked in roles of extensive team development and leadership, sales and marketing management, healthcare reimbursement and market access with both EMEA and international experience and a proven track record in delivering to commercial targets. She prides herself in her strong customer focus with excellent communication/presentation skills and a high degree of organisational flexibility. She previously worked at BMI Healthcare, Allergan and GSK and holds extensive qualifications in Marketing and an MBA. Clinically, she is familiar in a wide range of therapeutic areas including respiratory, diabetes, obesity and weight loss management and medical aesthetics. Driven by personal values of accountability, empowerment, focus and clarity, she is passionate about people and teams, firmly believing that results are achieved through inspiring and enabling others to act.
X
Emily Hough

Emily Hough Deputy Director, Strategy Group, NHS England

Emily Hough

Deputy Director, Strategy Group, NHS England

Emily Hough
Emily is one of the Deputy Directors within NHS England’s Strategy Group where she leads a number of programmes that were set out in the Five Year Forward View. This includes the Test Bed programme, which is looking to evaluate new combinations of innovations in real-world clinical settings to identify high-value innovations that will deliver health improvement at the same or less cost than existing practice.
X
Sean Hughes

Sean Hughes Director of Innovation, Customer Strategy and Innovation, Merck & Co

Sean Hughes

Director of Innovation, Customer Strategy and Innovation, Merck & Co

Sean Hughes
Sean Hughes is Director of Innovation and responsible for identifying relevant external and internal capabilities that support Merck/MSD’s strategic objectives, with a clear focus on addressing customers’ most pressing needs. He is a customer-focused professional with over 19 years of global experience in the pharmaceutical and healthcare industry. He began his career in 1994 by establishing a National Cardiac Disease Rehabilitation Program for the Heart Foundation of Barbados and joined Merck in 1998. He has held leadership positions for the company in the Caribbean, Latin American, the US and Canada and represented Merck on the Board of Directors of the Pan American Ophthalmological Foundation. From 1998-2006 he worked extensively in the HIV drug market. During this period he was involved in many aspects of business development and facilitated engagements with several multinational organizations including the World Bank, PAHO, PEFPAR and UNAIDS. As the National Director of Oncology and Specialty Medicines at Merck Canada, his team launched a breakthrough treatment in oncology and also formalized the Merck Canada Institutional Strategy for Hospitals nation-wide. In 2011 Sean moved to Merck’s Innovation Venture Unit, where he was intimately involved as a founding member of VreeHealth Llc., a wholly-owned subsidiary of Merck. He is now Director of Innnovation.
X
Martin Kelly

Martin Kelly CEO, HealthXL

Martin Kelly

CEO, HealthXL

Martin Kelly
Martin is the co-founder and CEO of healthXL.org – previously partner with IBM Ventures helping set-up their European operations. Martin advised the Irish government on their venture capital activities – aside from digital health he spends his spare time focus on 60’s soul, beer and rugby (but not at the same time).
X
Anna King

Anna King Commercial Director HIN, Health Innovation Network (HIN)

Anna King

Commercial Director HIN, Health Innovation Network (HIN)

Anna King
Anna has been Commercial Director at the Health Innovation Network since July 2013. Prior to her current role Anna was the Commercial Programme Director at the London Commercial Support Unit (Commissioning Support for London, NHS London and NHS Trust Development Authority). She managed the London Trusts’ Productivity Support Programme, including designing and implementing the Together to Improve Value Programme, working across 15 acute trusts in London, as well as programmes looking a nursing, diagnostics imaging, pathology and back office services. Anna also procured and managed a number of pan-London independent sector contracts, including Any Qualified Provider (AQP) for elective surgery, Diagnostics (InHealth), the North East London Treatment Centre (Care UK) and home oxygen. Anna was a Director with Grove Investments, and managed both bolt-on acquisitions for Barchester Healthcare (a leading provider of award winning, high-quality health and social care with over 14,000 staff) and investment in Trilogy Health Services (a skilled nursing, rehabilitation and assisted living business in the Midwest USA). Anna qualified as a Chartered Accountant with PricewaterhouseCoopers, and spent 13 years working there, primarily providing corporate finance advice to a wide range of health and social care clients, including GSK, Roche and Aventis.
X
Phil Koczan

Phil Koczan Chief Clinical Information Officer, North East London NHS Foundation Trust

Phil Koczan

Chief Clinical Information Officer, North East London NHS Foundation Trust

Phil Koczan
Phil is a clinical associate and has been a senior GP partner in a large practice for 21 years. He also has a long clinical informatics interest focusing on the use of clinical data to support the development of integrated patient care, commissioning and outcomes measurement. He is a member of the Royal College of GPs health informatics group and member of several national boards promoting both informatics and primary care including NHS England Open Source Programme and SCCI (Standardisation Committee for Care Information). Phil has been involved in several projects looking at how the delivery of care can be improved by the appropriate use of information systems, particularly ensuring that the right information is available to the right clinician at the right time to support integrated care whilst at the same time recognising security and patient confidentiality issues. Phil is experienced at providing clinical leadership to challenging projects, having previously provided clinical leadership to the “My Health London” project launched by the Mayor of London in 2011. He is the London clinical lead for the national “Patient on Line” programme which is providing patients access to their electronic primary care record and a first step in understanding how greater involvement of patients could support improvements in care and transformation of care delivery. He holds a wide range of skills and experience in the areas of Healthcare Information Technology, Healthcare Management, Change Management, Governance and Program Management, on top of his Clinical Research. Phil has held various informatics roles including: Chief Clinical Information Officer for UCLPartners, one of the Academic Health Science Networks. Chief Clinical Information Officer for North East London Foundation Trust Digital Clinical Champion for London and Essex with the Patient on Line Programme Clinical Lead for the London 111 integration Pilot
X
Zahid Latif

Zahid Latif Director of Population and Early Detection Research, Cancer Research UK

Zahid Latif

Director of Population and Early Detection Research, Cancer Research UK

Zahid Latif
A pharmacist by background, Zahid joined Cancer Research UK to lead on their research funding in the areas of Population Health and Early Detection. Zahid joined CRUK from Innovate UK where he was Head of Health and Care.
X
Charles Lowe

Charles Lowe Managing Director, DHACA

Charles Lowe

Managing Director, DHACA

Charles Lowe
DHACA is a free-to-join member-driven organisation dedicated to improving interoperability and reducing duplication in health and care systems. DHACA has 700 members, split across clinicians, suppliers (primarily SMEs) and commissioners, plus a few academics and consultants. DHACA’s objective is to identify appropriate resources and facilitate fruitful collaborations between the public sector, industry and the third sector, to expedite the development of new ways of delivering health and care that benefit all parties. DHACA has particular expertise in mHealth app assessment and regulation, wearables assessment and regulation, and IoT. Charles Lowe was educated at Cambridge and the London Business School. Following an early financial career, he led the creation of the BT Intranet as one of the first, largest and most successful corporate Intranets. He was at the centre of BT’s collaboration with the UK Government to deliver UKonline and other path-breaking public uses of the Internet. After BT he ran a large ICT/modernisation programme for the London Borough of Newham’s Social Services Departments where he established a large telecare programme with some 3,000 users. In 2007 Charles won Department of Health ‘Whole System Demonstrator’ funding for LB Newham to include telehealth. Charles’s telecare work won a 2008 NHS London Health & Social Care Innovation Award. Charles joined Telehealth Solutions in 2008 where he was responsible for product development and initial sales. In 2011 Charles joined Surrey County Council as Telecare and Telehealth Project Manager on a short contract to mainstream telecare and to run a £3.9m telehealth tender, both now successfully completed. Since 2013 he has built a portfolio of roles including Managing Director of the Digital Health and Care Alliance (DHACA) and assisting NetScientific plc in commercialising their data analytic service to improve substantially the predictive ability of telehealth.
X
Ben Lucas

Ben Lucas BU Director, Oncology, MSD UK HH LT

Ben Lucas

BU Director, Oncology, MSD UK HH LT

Ben Lucas
Ben is building the Oncology Franchise in the UK, having rejoined MSD in April 2014. Ben leads a cross-functional team with focus on accelerating the introduction and uptake of new, breakthrough oncology immunotherapy in the UK. Working with policy makers, and senior stakeholders at MHRA, NHS and NICE, the team were recently successful in providing access to cancer patients delivering the first medicine under the Early Access to Medicine Scheme (EAMS). Under Ben’s leadership the oncology team is committed to working collaboratively with the system to bring about the widespread adoption of new treatments that offer significant benefits to patients. Ben started his career working with elite athletes as an exercise physiologist at the Institute of Sport, Newcastle. He joined MSD in 1999 in his first role in pharmaceuticals and progressed through sales and marketing roles, before moving to Roche. He developed his experiences and expertise working in the Global organization in Basel, Switzerland before returning to lead the UK HER2 Breast Cancer Franchise and latterly the Anti-Angiogensis Franchise, overseeing the introduction of new formulations, expansion into new indications and the launch of multiple new molecular entities (NMEs). Ben is married, with five daughters and has lived in Sussex, Northumberland and North Yorkshire before settling in rural Hertfordshire. His interests (aside from parenting) include Rugby, Cycling, Golf, most spectator sports and country walks.
X
Dr. Mahiben Maruthappu

Dr. Mahiben Maruthappu Senior Fellow, Chair and Chief Executive’s Office, NHS England, NHSE

Dr. Mahiben Maruthappu

Senior Fellow, Chair and Chief Executive’s Office, NHS England, NHSE

Dr. Mahiben Maruthappu
Dr Mahiben Maruthappu is a practicing doctor and Senior Fellow to the CEO of NHS England. He advises on NHS England’s innovation, technology and prevention portfolio, co-founding the NHS Innovation Accelerator and the NHS Diabetes Prevention Programme. He has advised a range of organisations, from start-ups to multilaterals, including the Swiss government and the Experiment Fund and the World Health Organisation (WHO). Mahiben has a strong interest in research with over 80 peer-reviewed publications and 50 academic awards. His work has been featured by BBC News and the international press. He is Chairman of the UK Medical Students’ Association (UKMSA), and has written three medical books. Mahiben was educated at Oxford, Cambridge and Harvard universities and was the first person from British healthcare to be included in Forbes’ 30 under 30.
X
Dr Nadeem Moghal

Dr Nadeem Moghal Paediatrician and Medical Director of Barking, Havering & Redbridge University Hospital NHS Trust

Dr Nadeem Moghal

Paediatrician and Medical Director of Barking, Havering & Redbridge University Hospital NHS Trust

Dr Nadeem Moghal
Dr Moghal is a paediatrician and paediatric nephrologist who spent over 15 years as a consultant in Newcastle, where he led the tertiary level regional paediatric nephrology service. He transformed its primary purpose from one focused on delivering the various facets that define a renal service to one focused on preventing children reaching dialysis, achieving one of the highest pre-emptive transplant rates for a paediatric population – by redesigning the system of care, and spending no money. Forever wanting to improve the experience and outcomes for patients, he completed his MBA. This led to a fellowship at the NHS Institute, where he had the privilege of learning from the great minds at the Institute of Healthcare in Boston. As a quality improvement advisor, he has worked to improve and transform a wide range of services extending from a substance misuse community-based practice and a failing paediatric surgical ward, through to the flow of work in a super tertiary centre. He is passionate about delivering excellent clinical outcomes and a great patient experience, be it for the mother of a premature baby or the frail and elderly grandmother and her family; we will all be patients one day.
X
Michelle Mosolgo

Michelle Mosolgo IT Account management, MSD Global

Michelle Mosolgo

IT Account management, MSD Global

Michelle Mosolgo
As an experienced manager and technologist, Michelle has lead new innovative business ventures from startup to profitability in additional to implementation of enterprise wide system and services. She has extensive experience in strategy development and implementation of innovative technologies to support new lines of business. She has a strong understanding of healthcare policies and how to leverage the information to develop or improve business service offerings. She has worked in global environment for more than 20 years and has held various IT and business leadership roles across many aspect of the global pharmaceutical business. Michelle has experience supporting Basic Research, Clinical / Regulatory Systems, Marketing and Sales, Manufacturing and Corporate Systems in mature and emerging markets. She has lead large ERP programs in addition to global rollouts of enterprise systems and has operated a HR global shared service, utilizing SAP for personal administration and outsourcing for benefits and payroll.
X
Simon Nicholson

Simon Nicholson Director, Strategy Value Access, MSD UK HH LT

Simon Nicholson

Director, Strategy Value Access, MSD UK HH LT

Simon Nicholson
Simon Nicholson is the Market Access Director for MSD UK, having taken up this role in December 2015. Prior to his current role, Simon was the General Medicine Director and responsible for the sales and marketing teams aligned to the Diabetes and Cardiovascular business. Simon is passionate about improving patient experience and outcomes through innovative partnership working with the NHS. Simon built an innovative healthcare service business within MSD UK. This differentiated service portfolio includes healthcare analytics, clinical pathway design, patient engagement & coaching and telehealth services. Simon has a wealth of experience developing and implementing market access strategy in the pharmaceutical industry and has represented the industry on a variety of strategic initiatives in the NHS including Innovation Health and Wealth. Simon is married with three children and lives in Hertfordshire. He is a keen rugby coach, currently coaching in the junior section at Hertford RFC.
X
Dr. J. Nwando Olayiwola

Dr. J. Nwando Olayiwola Director, Center for Excellence in Primary Care, Associate Professor, Department of Family & Community Medicine Faculty Affiliate, UCSF Global Health Sciences

Dr. J. Nwando Olayiwola

Director, Center for Excellence in Primary Care, Associate Professor, Department of Family & Community Medicine Faculty Affiliate, UCSF Global Health Sciences

Dr. J. Nwando Olayiwola
Dr. Nwando Olayiwola is a family physician, the Director of the Center for Excellence in Primary Care, Associate Professor in the Department of Family and Community Medicine and Faculty Affiliate in Global Health Sciences at University of California, San Francisco. Her role is to support the Center in achieving strategic objectives around primary care transformation and systems redesign regionally, nationally and internationally. Prior to this, Dr. Olayiwola served as the Chief Medical Officer of the largest Federally Qualified Health Center system in Connecticut, Community Health Center, Inc. (CHCI), where she developed expertise in medical administration, translational and implementation research, professional development, systems based and quality improvement and practice transformation of twelve primary care practices into Patient-Centered Medical Homes. Her work led to CHCI being one of the first organizations in the United States to receive both the NCQA Level 3 PCMH and Joint Commission PCMH Recognitions. She has been a leader in harnessing technology to increase access to care for underserved and disenfranchised populations and is an expert in the areas of health systems reform, practice transformation, health information technology and primary care redesign. She has contributed to primary care transformation and health systems strengthening across the United States and in Singapore, Ireland, United Arab Emirates, Australia and for the European Forum for Primary Care. Dr. Olayiwola, a champion of diversity and inclusion in medicine, is also a Faculty Lead for the UCSF School of Medicine’s innovative Differences Matter initiative. Since 2007, Dr. Olayiwola has been named one of America’s Top Family Doctors by the Consumers Research Council of America annually. She received the Excellence in Medicine Leadership Award from the American Medical Association in March 2005 and was honored as a Fellow of the American Academy of Family Physicians in October 2007. In October 2008, she was one of three physicians in the nation to receive the Emerging Leaders Award from the Family Medicine Education Consortium and the Society for Teachers of Family Medicine and in September 2009, she received the William Oxley Thompson Award for Early Career Achievement from the Ohio State University Alumni Association. In 2011, Dr. Olayiwola was named one of the Top 40 Physicians Under 40 by the National Medical Association and was also named as one of the Top 100 Buckeyes You Should Know by the Ohio State University Alumni Association. In October 2012, she received the Early Career Achievement Award from the Ohio State University College of Medicine, which is presented “to an alumnus who has made significant contributions in the community, scientific or academic achievement before the age of 40”. Dr. Olayiwola was selected as one of thirty UCSF Young Innovators for their 150th Anniversary in April 2014. She was named a Marshall Memorial Fellow by the German Marshall Fund in 2014 and received the Harvard School of Public Health’s Emerging Public Health Professional Award in October 2014. She has been a member the Advisory Board of the Robert Graham Center for Policy Studies in Family Medicine & Primary Care since 2015 and appointed as the Health Sciences Representative to The Ohio State University Alumni Advisory Council since 2013. Dr. Olayiwola has published extensively in peer-reviewed journals and is also the author of multiple works of poetry and three creative books, including Half Woman, Medicine is Not a Job, and Minority Women Professionals (MWPs) are MVPs. Dr. Olayiwola was a Commonwealth Fund/Harvard University Fellow in Minority Health Policy at Harvard Medical School from 2004 to 2005. During this fellowship and leadership training, she received her master’s degree in public health with a concentration in health policy from the Harvard School of Public Health, and was also a Presidential Scholar. She obtained her undergraduate degree in Human Nutrition/Pre-Medicine at the Ohio State University, Summa Cum Laude and With Distinction, and her medical degree from the Ohio State University/Cleveland Clinic Foundation. She completed her residency training in family medicine at Columbia University/New York Presbyterian Hospital, where she was a Chief Resident. In 2013, she was inducted into the American College of Physician Executives after completing the Certified Physician Executive program in 2012.”
X
Ash Pandya

Ash Pandya Chief Executive, Essex Local Pharmaceutical Committee

Ash Pandya

Chief Executive, Essex Local Pharmaceutical Committee

Ash Pandya
Ash joined the Essex Local Pharmaceutical Committee (LPC) in 2007 as Business Development Manager and was appointed Chief Executive in April 2009. He was a contractor for 14 years and worked for 10 years as the National Commissioning Manager at NHS Direct.
X
Dr Ranil Perera

Dr Ranil Perera Lead GP and Lead on IT/Clinical Lead, Greenwich CCG/Conway PMS/Bincote Road Surgery (GP)

Dr Ranil Perera

Lead GP and Lead on IT/Clinical Lead, Greenwich CCG/Conway PMS/Bincote Road Surgery (GP)

Dr Ranil Perera
Dr Ranil Perera, a GP since 2001, practices at Conway PMS Medical Centre in Plumstead; He joined the CCG Governing Body as a GP Commissioner in 2014.  In the two years prior to joining the Governing Body, Dr Perera was the Clinical Project Lead (CPL) on the Greenwich Referral Management Service (RMBS) and contract monitoring. As a GP Commissioner on the Governing Body, Dr Perera is the lead for mental health care. He is the CCG’s Caldicott Guardian and as the quality assurance lead, Dr Perera oversees the relationship between NHS England and the CCG in respect of quality assurance issues.  On behalf of the Governing Body, Dr Perera is also responsible for information technology and business intelligence, which builds on Dr Perera’s interest in exploring how technology can be used to enhance the patient experience and make life easier for clinicians. Dr Perera is an advisor to the General Medical Council on disability issues.  Outside of clinical practice, Dr Perera’s interests range from neurolinguistics and psychology to archery to sports and exercise medicine.  Additionally, Dr Perera regularly shares his flair for magic and comics with his younger patients. He has lived in London since 2006 with his young family.
X
Stephen Ranjan

Stephen Ranjan Exec Director, Customer Strategy & Innovation, MSD Global

Stephen Ranjan

Exec Director, Customer Strategy & Innovation, MSD Global

Stephen Ranjan
Stephen is an accomplished healthcare management professional with nearly 15 years experience in pharmaceutical solution marketing, business strategy, account management, new product development and launch, and healthcare delivery transformation. He has an outstanding track record in managing at risk projects and successfully getting them back on track. He has a built a foundation of strong cross-functional leadership skills with the ability to bring various domain experts to the table in order to successfully transform healthcare delivered to patients. You can read more about Stephen on his LinkedIn page
X
Jane Rogers

Jane Rogers Digital Communications Manager at Central and North West London NHS Foundation Trust

Jane Rogers

Digital Communications Manager at Central and North West London NHS Foundation Trust

Jane Rogers
Jane is Digital Communications Manager at Central and North West London NHS Foundation Trust (CNWL). CNWL has almost 7,000 staff providing integrated healthcare to a third of London’s population, Milton Keynes and areas beyond. Jane has played a leading role in brand strategy development, marketing campaign generation, website traffic growth, advertising, graphic design, ROI analysis, and media planning. A multi-lingual individual, Jane builds upon her experience in a variety of Marketing roles.
X
Andy Ross

Andy Ross Managing Director and General Manager, EMEA, Infusion

Andy Ross

Managing Director and General Manager, EMEA, Infusion

Andy Ross
Andy is the General Manager for EMEA at Infusion, and has over 15 years of experience as a senior executive in technology organisations. He leads Infusion’s team in EMEA and is focused on helping clients to digitise through the use of emerging technology. He also manages some of Infusion’s largest relationships with both clients and partners. Infusion is a digital technology consultancy that helps enterprises design and build digital solutions that transform their businesses.
X
Chris Sawyer

Chris Sawyer Head Technologist, Independent Living Programme, Innovate UK

Chris Sawyer

Head Technologist, Independent Living Programme, Innovate UK

Chris Sawyer
Chris’s responsibility is to determine which science and technology developments will drive future economic growth and to meet UK innovators with great ideas in the fields being focused on. To fund the strongest opportunites, connect innovators with the right partners they need to succeed and help innovators launch, build and grow successful businesses. He is a Lead Technologist working on the Assisted Living Innovation Platform. In his role, he is engaged in helping deliver new healthcare solutions. Before joining Innovate UK, he worked with various Innovation Hubs and undertook several consultancy engagements.
X
Susan Sinclair

Susan Sinclair CEO, AT Medics

Susan Sinclair

CEO, AT Medics

Susan Sinclair
Susan is an experienced healthcare leader with extensive experience of turnaround and transformation, in a variety of settings. She has broad operational management experience in variety of roles and sectors, including Acute Sector, Commissioning, and Academic Sector. She has extensive experience in forming partnerships with clinical leaders to successfully deliver ambitious aims and objectives. A registered nurse by profession, she was previously Director of Strategy at West Middlesex University Hospital and Deputy Director at NHS North West London.
X
Tamir Singer

Tamir Singer Consultant

Tamir Singer

Consultant

Tamir Singer
Originally from Tel-Aviv, Israel. Tamir is a management consultant with cross-industry experience and a specialty in strategy and business development in healthcare. He used to work for Barts Health, the largest provider in the UK covering north-east London, initiating and setting up commercial programmes to work with business partners. He then took a role in HCA, a leading private provider in the US and the UK, and led their business development activities with the NHS, designing and delivering commercial models that actually work. Currently, he provides consulting services to a variety of healthcare companies and mentoring their leaders. He is highly experienced in strategy and business development – designing new propositions, developing commercial models for partnerships and their financial models, assessing markets, and identifying new opportunities to grow. He also has extensive insight into setting up and running programmes to make things happen while working with blue-chip corporates, SMEs, and startups. He is keen to help health-tech companies to grow, rump-up sales, build partnerships, or anything else that makes them more successful.
X
Oliver Smith

Oliver Smith Director of Strategy and Innovation, GSTT Charities

Oliver Smith

Director of Strategy and Innovation, GSTT Charities

Oliver Smith
Ollie Smith joined the charity in 2010 as Director of Strategy and Innovation. He was previously a Deputy Director at the Department of Health, where he led a diverse range of health and health care policy and strategy initiatives. His earlier experience includes working in the Prime Minister’s Strategy Unit.
X
Harpreet Sood

Harpreet Sood Senior Fellow, Chair and Chief Executive’s Office, NHS England, NHSE

Harpreet Sood

Senior Fellow, Chair and Chief Executive’s Office, NHS England, NHSE

Harpreet Sood
Dr Harpreet Sood is currently Senior Fellow to the Chairman and Chief Executive’s Office of NHS England. Harpreet trained as a clinical doctor at King’s College London and Imperial College Business School and practiced as an academic trainee in East London. Following this he did a Masters in Public Health (MPH) at Harvard University, where he focused on international health policy and co-founded a digital health start-up. Post MPH, Harpreet was a Deland Fellow in health policy and management at Brigham and Women’s Hospital, a large academic medical centre in Boston. Harpreet’s portfolio of work at NHS England includes implementing the National Diabetes Prevention Programme.
X
Mary Stahl

Mary Stahl Vice Consol Key Accounts, UK Trade & Investment

Mary Stahl

Vice Consol Key Accounts, UK Trade & Investment

Mary Stahl
Mary’s responsibility is to help identify and enable UK investment opportunities for the large US pharmaceutical companies. Her focus is on UK start-ups, spin outs, R & D collaborations at the university level, partnerships and aligning strategic developments. Mary and the global UKTI team, help British companies with innovation, creativity and cutting-edge technology, grow.
X
Hal Stern

Hal Stern Exec Director, IT Architecture, Applied Technology, MSD Global

Hal Stern

Exec Director, IT Architecture, Applied Technology, MSD Global

Hal Stern
Hal Stern is Executive Director of Applied Technology at MSD, where he focuses on building services and applications to define and shape the data-oriented and data-influenced adjacencies to MSD’s core markets. Hal was previously a VP at Juniper Networks and spent more than 20 years at Sun Microsystems, in a variety of technical leadership roles. He holds a BSE degree in Electrical Engineering and Computer Science from Princeton University and holds four issued and several filed patents in the areas of security, identity, user experience, and networking. Hal has been a frequent speaker at industry and technical conferences, and has co-authored three books, “Professional WordPress: Design and Development” (2010), “Blueprints for High Availability” (2001) and “Managing NFS and NIS” (1991). He is an active Kiva microlender and digital photographer, and may be found on the left wing with his adult ice hockey team, cheering for the NJ Devils, building guitar electronics, or playing golf very badly.
X
Dr Aumran Tahir

Dr Aumran Tahir Founder & Director, CCIO and Quality Improvement Lead, AT Medics

Dr Aumran Tahir

Founder & Director, CCIO and Quality Improvement Lead, AT Medics

Dr Aumran Tahir
Dr Tahir graduated from St. George’s, University of London in 1999 and has significant experience in leading and delivering highly successful services and transformations in extremely challenging situations. He has held posts in integrated care including the Clinical Director of the North West London Whole Systems Integrated Care Programme. He is an experienced GP specialist trainer for the London Specialty School of General Practice and has successfully mentored both GPs and GP “trainees in difficulty”. He is an Honorary Senior Research Fellow at the University of Surrey (Healthcare Management & Policy) and a Health Foundation Quality Improvement Fellow. He is also Faculty Honorary Secretary for the North West London RCGP Faculty.
X
Desney Tan

Desney Tan Senior Director, Microsoft Medical Devices Group

Desney Tan

Senior Director, Microsoft Medical Devices Group

Desney Tan
Desney runs the Microsoft Medical Devices Group, which focuses on technology solutions for cardiovascular disease. Desney is responsible for creating vision, defining strategy, overseeing execution, and growing new lines of business. On the personal front, he is also an avid angel investor with a reasonably broad technology portfolio.
X
Jenny Thomas

Jenny Thomas DigitalHealth.London, Accelerator Programme Director

Jenny Thomas

DigitalHealth.London, Accelerator Programme Director

Jenny Thomas
Jenny joins the programme as lead for the DigitalHealth.London Accelerator. She is passionate about digital health and supporting both SMEs and the NHS to rapidly realise the benefits from this emerging sector. Prior to her current role, Jenny was the General Manager for Women’s Services at Guy’s and St Thomas’ Hospital. She started her career in the NHS in 2006 as a Graduate Management trainee and since then has held a number of operational and strategic roles in the NHS and overseas. Jenny has an MBA from the London Business School and a Masters in Healthcare management from Manchester Business School
X
Wim Vandenhouweele

Wim Vandenhouweele Commercial Innovation Leader Europe, Canada and Emerging Markets, MSD Global

Wim Vandenhouweele

Commercial Innovation Leader Europe, Canada and Emerging Markets, MSD Global

Wim Vandenhouweele
Wim Vandenhouweele was born in Belgium, has a Masters in Sports-physiology at University Ghent, Belgium, Marketing at EHSAL Brussels, Belgium and IEP at INSEAD, Fontainebleau, France. After joining MSD/Merck Belgium in 1983, he has worked also in MSD Netherlands, MSD China and Merck’s global headquarters in the US, in sales, country, regional and global marketing, strategy, PPP and commercial operation roles. Currently, he is Commercial Innovation Leader Europe, Canada and Emerging Markets. He is based in the US (New Jersey) and works very closely with country teams to manage a portfolio of the most innovative initiatives through ideation, experimentation and pilot stages, with multiple of them now being scaled across many countries. He also partners with Regional / Country Innovation Leaders to further build, in each country, a climate that stimulates innovation, through networks, capability building, collaboration, communication and recognition.
X
Michael Wright

Michael Wright Head of Investment, GSTT Charities

Michael Wright

Head of Investment, GSTT Charities

Michael Wright
Michael Wright is currently Head of Investments at Guy’s and St Thomas’ Charity. This involves management of an investment fund supporting innovation in Medical Devices, Diagnostics, Mechanical Aids and Software. He is also responsible for sourcing, evaluating and investing in Healthcare companies with non-therapeutic medical innovations and companies delivering laboratory services to the UK NHS. Michael holds a PhD in Applied Microbiology and Biochemistry from Cranfield University and an MBA. Previously, he was Managing Director of EKB Technology Ltd and the Director of Southern Oxfordshire Hub.
X
Professor Tony Young PhD

Professor Tony Young PhD National Clinical Lead for Innovation, NHS England, President Institute of Decontamination Sciences, Director of Medical Innovation, Anglia Ruskin University.

Professor Tony Young PhD

National Clinical Lead for Innovation, NHS England, President Institute of Decontamination Sciences, Director of Medical Innovation, Anglia Ruskin University.

Professor Tony Young PhD
Tony is a practicing frontline NHS surgeon, Director of Medical Innovation at Anglia Ruskin University, and has founded four Med-Tech start-ups. He has also co-founded the £500m Anglia Ruskin Med Tech Campus, which will become one of the world’s largest health innovation spaces. In 2014 he was appointed as National Clinical Director for Innovation at NHS England and in February 2016 became the first National Clinical Lead for Innovation. In this role he provides clinical leadership and support in delivering improved health outcomes in England and drives the uptake of proven innovations across the NHS, promotes economic growth through innovation and helps make the NHS the go-to place on the planet for medical innovation.
X
Jonathan Anscombe

Jonathan Anscombe Partner, Europe, Middle East, and Africa, A.T. Kearney

Jonathan Anscombe

Partner, Europe, Middle East, and Africa, A.T. Kearney

Jonathan Anscombe
Jonathan is a Partner at A.T. Kearney with over 25 years of consulting experience, mostly spent in health. He has held a variety roles including leading the EMEA Health Practice and Global Transformation Practice. He has worked across the health ecosystem in Europe, USA and Japan advising pharmaceutical companies, pharmacies, wholesalers, private healthcare companies, Governments, hospitals, and health insurers across the value chain from policy, through strategy to execution.

In recent years he has focussed on digital transformation and new business models, particularly omni-channel customer engagement and developing “beyond the pill” solutions. He also developed a cross industry technology enabled innovation process called DBX. He is a prolific author, developing new insights on global health and technology trends.

X
Mark Leaning

Mark Leaning Chairman, Helicon Health

Mark Leaning

Chairman, Helicon Health

Mark Leaning
Mark Leaning is an engineer and successful serial entrepreneur with a passion for transforming healthcare for the better with technology. His work spans primary care to intensive care, from prevention to the critically ill and injured, and has led to large-scale market adoption, listings, acquisitions and the development of groundbreaking products.

He is Chairman of Helicon Health, which provides digital health services for both clinicians and patients to improve outcomes of chronic diseases such as atrial fibrillation, and Founder of Directed Systems Ltd, which is developing advanced decision support and closed-loop care systems to improve safety, outcomes and efficiency in critical care.

Mark was CEO of Applied Physiology, a medical device company he founded whilst in Australia. Under Mark’s leadership, the company raised $15m in equity and non-dilutive grant funding and developed Navigator, an innovative and world-first CE Marked and FDA approved real-time critical care cardiovascular decision support system.

Previously, as Executive Director at HCN, Australia’s leading supplier of clinical GP systems, Mark led the M&A program and played a key role in its $50m listing on the ASX. HCN was subsequently sold and realized $100m for its shareholders. Before HCN, while living in the United States, Mark was Chief Operating Officer of Preferred Health Systems, an integrated health management software company he co-founded, which was acquired by Magellan Health Services.

Mark has an engineering degree from Cambridge University, followed by an MSc and PhD in Systems Engineering from City University. He is a Visiting Professor at University College London and an advisor on Industry to the UCL Institute of Digital Health. He researches and publishes on a range of subjects including biomedical engineering, mathematical modelling, artificial intelligence and digital health. Mark is also a successful inventor and product developer, having brought several new products to the health market.

X
Bruce Kynoch

Bruce Kynoch Head of Communications and Engagement, NHS England

Bruce Kynoch

Head of Communications and Engagement, NHS England

Bruce Kynoch
Bruce is currently Head of Communications and Engagement for the national new care models programme at NHS England-supporting the NHS to develop a blueprint for future health and social care services.

With a strong digital healthcare marketing and communications background and understanding of the landscape, Bruce has supported the launch of innovations across the NHS, pharmaceutical industry and private healthcare environments. Formerly working with NHS Digital, the myhealthlondon platform and launch of the WellHappy App.

X
Bethan Bishop

Bethan Bishop Director, Aliciyo Ltd.

Bethan Bishop

Director, Aliciyo Ltd.

Bethan Bishop
“Bethan is a strategic leader in health innovation and passionate about developing and harnessing talent. She founded Aliciyo to focus her work with businesses and investors to increase their impact in healthcare. Beth is quick to assess the most effective way of developing a new product or service, scoping projects to provide evidence of value for the right audience and for adoption at scale. She is at her best when providing strategic insight, making connections across her network, maximising her years of knowledge and expertise of working within and across the UK health system. Beth believes that global healthcare systems will only be successful if we innovate within them and around them. Partnership working which involves leveraging the expertise from small to large healthcare businesses and other sectors is key to this.

Beth has developed a distinctive 20+ year career within the pharmaceutical industry (Pfizer, Adelphi Group, PPD Development) and healthcare. Prior to founding Aliciyo she worked for over 16 years in the NHS where she led innovation, research and industry engagement. Throughout this time she worked with hundreds of healthcare businesses (majority of these being tech focussed or digitally enabled), through NHS, EU, industry and investor funded programmes, helping them to develop their business strategies and engage with the right NHS staff & organisations and in the right way.

Beth currently works with a wide range of investors and businesses from large blue chip organisations and the public sector, including the West Midlands Academic Health Science Network (Serendip Smart Cities Incubator), Birmingham Science City Alliance & EIT Health through to the smallest of SMEs with solutions spanning social care, public health and direct to consumer markets.

X
Claire Oatway

Claire Oatway Chief Operating Officer, Beacon Medical Group

Claire Oatway

Chief Operating Officer, Beacon Medical Group

Claire Oatway
Beacon Medical Group is a GP Super Practice supporting 40,000 patients across Plymouth and South Devon. Newly formed and high energy, the group has quickly established a national reputation for disruption and for delivering new styles of care in the community.

Beacon is a national rapid test site for Primary Care Home – an NHS England and National Association of Primary Care initiative supporting practices to take on leadership and control for the broader health and care, health and wellbeing system in their area. We’ve taken that opportunity to get a really clear idea of the needs of our population, to blur the boundaries between different providers and to encourage more ownership and engagement from patients in their own care.

For some time, we’ve seen that technology is a huge enabler in that agenda and have been working with local, regional and national players to create a med tech buzz in the far south west. We’ve hosted TEDMEDLive for 2 years running and established a social movement – Hipster which brings technologists together to solve big health problems.

X
Dr. Tim Bray

Dr. Tim Bray GP Partner & Research Lead, Beacon Medical Group

Dr. Tim Bray

GP Partner & Research Lead, Beacon Medical Group

Dr. Tim Bray
Dr. Tim Bray is a full time GP Partner & the Research Lead of Beacon Medical Group, a GP “”Super Practice”” of 40,000 patients with an international reputation for primary care innovation. As a founding Partner, he has been heavily involved in a series of innovations in terms of pathway and workforce redesign, with a particular interest in population health & long term condition management enabled through medical technology.

Tim is also a Principle Investigator and is responsible for the successful delivery of a portfolio of clinical trials to over 40,000 patients. He is an elected board member of Devon LMC Western Sub-Commitee and GP trainer.

He recently has also taken a role on the Clinical Studies Group for Diabetes UK and supported SBRI in an advisory position for their “”GP of the Future”” competition.

X

Become An Explorer